{"published":"2019-08-22 15:46:19","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fbiotechgroup.hatenablog.com%2Fentry%2F2019%2F08%2F22%2F154619\" title=\"We Are Consulting About the Control Process for The Medical Design - biotechgroup\u2019s diary\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","type":"rich","provider_name":"Hatena Blog","width":"100%","author_url":"https://blog.hatena.ne.jp/biotechgroup/","version":"1.0","url":"https://biotechgroup.hatenablog.com/entry/2019/08/22/154619","categories":[],"author_name":"biotechgroup","description":"The biologics business is heavily regulated with FDA\u2019s dynamical landscape of regulative elements. The FDA has an objective to make sure biologics firms providing safe and effective biological merchandise to the general public. The middle for pharma consulting and analysis is to blame for the review\u2026","blog_title":"biotechgroup\u2019s diary","title":"We Are Consulting About the Control Process for The Medical Design","provider_url":"https://hatena.blog","height":"190","blog_url":"https://biotechgroup.hatenablog.com/","image_url":null}